The evolution and clinical impact of hepatitis B virus genome diversity
The global burden of hepatitis B virus (HBV) is enormous, with 257 million persons
chronically infected, resulting in more than 880,000 deaths per year worldwide. HBV exists …
chronically infected, resulting in more than 880,000 deaths per year worldwide. HBV exists …
Hepatitis delta virus
SA Hughes, H Wedemeyer, PM Harrison - The Lancet, 2011 - thelancet.com
Hepatitis delta virus (HDV) is a small, defective RNA virus that can infect only individuals
who have hepatitis B virus (HBV); worldwide more than 15 million people are co-infected …
who have hepatitis B virus (HBV); worldwide more than 15 million people are co-infected …
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …
EASL Clinical Practice Guidelines on hepatitis delta virus
Hepatitis D virus (HDV) is a defective virus that requires the hepatitis B virus to complete its
life cycle and cause liver damage in humans. HDV is responsible for rare acute and chronic …
life cycle and cause liver damage in humans. HDV is responsible for rare acute and chronic …
[HTML][HTML] EASL clinical practice guidelines: management of chronic hepatitis B virus infection
European Association For The Study Of The Liver - Journal of hepatology, 2012 - Elsevier
Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease is continuously improving. New data have become …
for therapy of the resultant disease is continuously improving. New data have become …
[PDF][PDF] Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta
Interferon alpha is the only treatment option for hepatitis delta virus (HDV). Trials
investigating the efficacy of pegylated interferon alpha (PEG‐IFNa) showed HDV RNA …
investigating the efficacy of pegylated interferon alpha (PEG‐IFNa) showed HDV RNA …
[HTML][HTML] A review on hepatitis D: From virology to new therapies
N Mentha, S Clément, F Negro, D Alfaiate - Journal of advanced research, 2019 - Elsevier
Hepatitis delta virus (HDV) is a defective virus that requires the hepatitis B virus (HBV) to
complete its life cycle in human hepatocytes. HDV virions contain an envelope incorporating …
complete its life cycle in human hepatocytes. HDV virions contain an envelope incorporating …
Clinical features of hepatitis D
P Farci, GA Niro - Seminars in liver disease, 2012 - thieme-connect.com
Hepatitis D is caused by infection with hepatitis D virus (HDV), a defective RNA virus that
requires the obligatory helper function of hepatitis B virus (HBV) for its in vivo transmission …
requires the obligatory helper function of hepatitis B virus (HBV) for its in vivo transmission …
[PDF][PDF] Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation
M Lütgehetmann, LV Mancke, T Volz, M Helbig… - …, 2012 - Wiley Online Library
No specific drugs are currently available against hepatitis delta virus (HDV), a defective virus
leading to the most severe form of chronic viral hepatitis in man. The lack of convenient HDV …
leading to the most severe form of chronic viral hepatitis in man. The lack of convenient HDV …
Hepatitis delta: virological and clinical aspects
LF Botelho-Souza, MPA Vasconcelos, AO Dos Santos… - Virology journal, 2017 - Springer
There are an estimated 400 million chronic carriers of HBV worldwide; between 15 and 20
million have serological evidence of exposure to HDV. Traditionally, regions with high rates …
million have serological evidence of exposure to HDV. Traditionally, regions with high rates …